CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Magazine

Past Issues

  • Dece-2022-Janu 2023
    Clinical Lab Equipment

    Contents

  • December-01 2022
    Proteomics

    Contents

  • November-24 2022
    Clinical Microbiology

    Contents

  • November-17 2022
    Marketing

    Contents

  • November-14 2022
    Synthetic Biology

    Contents

  • October-20 2022
    CRO

    Contents

  • October-10 2022
    HEOR

    Contents

  • Magazine Archive

Regulatory Services Special- January-30, 2023

Top 10 Regulatory Services Companies – 2023

Contents

How Technology Enhances the Effectiveness of Compliance Programs

January-30

View Digital Version

  • 8

    Artificial Intelligence and the Healthcare Industry

    Kelly H. Zou, PhD., PStat®, FASA, Head of Global Medical Analytics and Real World Evidence, Viatris

  • 12

    How Technology Enhances the Effectiveness of Compliance Programs

    Patrik Florencio, Svp and Chief Compliance & Risk Officer, Amicus Therapeutics

  • 19

    Challenges And Opportunities For AI In Drug Discovery

    Robert J. Prill, and Yong Yue, Director, Data Science and AI, Computational Biology and Data Sciences, and Senior Director, Computational Biology and Data Sciences, Ferring Research Institute, Inc.

  • 22

    Advanced Therapies for Patients Suffering from PAH

    Shola Oyewole, CIO, United Therapeutics Corporation [NASDAQ:UTHR]

  • 24

    Setting a Culture for Digital Transformation in the Biopharmaceutical Industry

    Ross Kenyon, P.E. , Associate Director, Modeling, Simulation and Analysis, Regeneron Pharmaceuticals

  • 26

    Analytical Considerations for Combination Products

    Jennifer L. Riter, Sr. Director, Business and Technical Operations, Services and Solutions, West Pharmaceutical Services, Inc.

  • 28

    Three C’s to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical Ingredient

    Nick Thomson, Senior Director, Chemical Research and Development, Pfizer Inc

  • 30

    From ideation to portfolio program: Innovation vs validation in early drug discovery

    Carlos Pedraza, PhD., Director of CNS Biology, Alkermes

Featured Vendors

Facet Life Sciences: Helping Break New Scientific and Regulatory Ground

Facet Life Sciences: Helping Break...

Ken VanLuvanee, President and CEO

CCS Associates: Active Research and Development Strategies for the Pharma World

CCS Associates: Active Research and...

Caroline Sigman, President, CEO

A Novel Treatment for Botulinum Neurotoxin (BoNT) Adverse Effects

A Novel Treatment for Botulinum...

Steve Yoelin, M.D., Chief Medical Strategist

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/magazine/